docetaxel anhydrous has been researched along with Neuroectodermal Tumors, Primitive, Peripheral in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bernstein, ML; Bomgaars, LR; Collier, AB; Dang, HM; DuBois, SG; Gorlick, RG; Hawkins, DS; Janeway, KA; Krailo, MD; Reed, DR | 1 |
1 trial(s) available for docetaxel anhydrous and Neuroectodermal Tumors, Primitive, Peripheral
| Article | Year |
|---|---|
Outcome of patients with relapsed or progressive Ewing sarcoma enrolled on cooperative group phase 2 clinical trials: A report from the Children's Oncology Group.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Neoplasms; Child; Docetaxel; Humans; Neoplasm Recurrence, Local; Neuroectodermal Tumors, Primitive, Peripheral; Sarcoma, Ewing | 2021 |